Curis (CRIS) Misses Q1 EPS by 2c, Beat on Revenues
Tweet
Share
E-mailGet Alerts CRIS Hot Sheet
Price: $0.32 +52.38%
Revenue Growth %: +13.0%
Financial Fact:
General and administrative: 4.68M
Today's EPS Names:
CGEH, NAKA, APOG, More
Revenue Growth %: +13.0%
Financial Fact:
General and administrative: 4.68M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Curis (NASDAQ: CRIS) reported Q1 EPS of ($0.11), $0.02 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $2.19 million versus the consensus estimate of $1.98 million.
For earnings history and earnings-related data on Curis (CRIS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of Reverse Stock Split
- Curis opens 11 CLL trial sites, stockholders approve reverse split
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
